News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
775,679 Results
Type
Article (55322)
Company Profile (204)
Press Release (720125)
Multimedia
Podcasts (238)
Webinars (38)
Section
Business (243564)
Career Advice (2913)
Deals (37577)
Drug Delivery (212)
Drug Development (84973)
Employer Resources (189)
FDA (17851)
Job Trends (15750)
News (362319)
Policy (34888)
Tag
2027 BioCapital Elite (1)
2027 BioCapital Standard (2)
2027 BioMidwest Elite (2)
2027 BioMidwest Standard (2)
2027 Bio NC Standard (3)
2027 Biotech Bay Elite (4)
2027 Biotech Bay Standard (8)
2027 Biotech Beach Digital (1)
2027 Biotech Beach Elite (3)
2027 Biotech Beach Standard (5)
2027 Genetown Elite (4)
2027 Genetown Standard (10)
2027 Pharm Country Elite (2)
2027 Pharm Country Standard (8)
Academia (2740)
Academic (1)
Accelerated approval (69)
ADA (49)
Adcomms (44)
Allergies (210)
Alliances (53403)
ALS (262)
Alzheimer's disease (2057)
Antibody-drug conjugate (ADC) (664)
Approvals (18354)
Artificial intelligence (968)
ASCO (337)
Autoimmune disease (446)
Automation (78)
Bankruptcy (383)
Belgium (13)
Best Places to Work (11768)
BIO (81)
Biologics (24)
BIOSECURE Act (23)
Biosimilars (288)
BioSpace Insights (215)
Biotechnology (129)
Bispecific (6)
Bladder cancer (229)
Brain cancer (92)
Breast cancer (863)
Cancer (7145)
Cardiovascular disease (621)
Career advice (2503)
Career pathing (62)
CAR-T (416)
CDC (78)
CDMO (190)
Celiac Disease (3)
Cell-line development (2)
Cell therapy (1129)
Cervical cancer (61)
Clinical research (74864)
Collaboration (2649)
Commercialization (14)
Company closure (10)
Compensation (1785)
Complete response letters (123)
COVID-19 (2967)
CRISPR (135)
C-suite (1569)
Cystic fibrosis (172)
Data (9651)
Decentralized trials (3)
Denatured (84)
Depression (216)
Dermatology (147)
Diabetes (745)
Diagnostics (7337)
Digital health (70)
Diversity (14)
Diversity, equity & inclusion (45)
Drug discovery (474)
Drug pricing (250)
Drug shortages (35)
Duchenne muscular dystrophy (368)
Earnings (92509)
Editorial (84)
Employer branding (24)
Employer resources (169)
Events (124744)
Executive appointments (1312)
Eye disease (3)
FDA (22587)
Fibrodysplasia Ossificans Progressiva (12)
Friedreich's ataxia (26)
Frontotemporal dementia (38)
Funding (2156)
Gene editing (286)
Generative AI (88)
Gene therapy (893)
GLP-1 (1329)
Government (4816)
Grass and pollen (8)
Guidances (430)
Healthcare (19148)
Hematology (184)
HIV (111)
Huntington's disease (78)
Idiopathic pulmonary fibrosis (3)
IgA nephropathy (137)
Immunology and inflammation (401)
Immuno-oncology (135)
Indications (256)
Infectious disease (3389)
Inflammatory bowel disease (245)
Inflation Reduction Act (16)
Influenza (158)
Intellectual property (361)
Interviews (537)
IPO (17110)
IRA (60)
Job creations (4229)
Job search strategy (2043)
JPM (72)
Kidney cancer (28)
Kidney disease (97)
Labor market (136)
Layoffs (697)
Leadership (64)
Legal (8530)
Licensing (43)
Liver cancer (114)
Longevity (47)
Lung cancer (985)
Lymphoma (519)
Machine learning (73)
Management (67)
Manufacturing (1484)
Marketing (13)
MASH (238)
Medical affairs (3)
Medical device (14550)
Medtech (14813)
Mergers & acquisitions (21946)
Metabolic disorders (1959)
mRNA (303)
Multiple sclerosis (229)
Multispecific (1)
NASH (23)
Netherlands (11)
Neurodegenerative disease (570)
Neuropsychiatric disorders (145)
Neuroscience (4032)
Neurotech (2)
NextGen: Class of 2026 (6793)
Non-profit (4299)
Now hiring (92)
Obesity (951)
Opinion (387)
Ovarian cancer (262)
Pain (313)
Pancreatic cancer (403)
Parkinson's disease (451)
Partnered (46)
Patents (753)
Patient recruitment (936)
Patient selection (27)
Peanut (72)
People (63801)
Peptides (9)
Pharmaceutical (55)
Pharmacy benefit managers (40)
Phase 1 (23073)
Phase 2 (32718)
Phase 3 (25074)
Pipeline (12526)
Policy (411)
Postmarket research (2764)
Preclinical (9687)
Press Release (68)
Prostate cancer (375)
Psychedelics (94)
Radioligand (1)
Radiopharmaceuticals (408)
Rare diseases (1477)
Real estate (6616)
Recruiting (76)
Regenerative medicine (9)
Regulatory (28689)
Reports (73)
Research institute (2548)
Resumes & cover letters (458)
Rett syndrome (53)
RNA editing (31)
RSV (101)
Schizophrenia (210)
Series A (386)
Series B (273)
Service/supplier (12)
Sickle cell disease (135)
Special edition (36)
Spinal muscular atrophy (187)
Sponsored (58)
Startups (4037)
State (2)
Stem cells (1)
Stomach cancer (22)
Substance use disorders (21)
Supply chain (159)
Tariffs (105)
The Weekly (152)
Vaccines (1366)
Venture capital (166)
Weight loss (641)
Wet AMD (1)
Women's health (168)
Worklife (27)
Date
Today (169)
Last 7 days (609)
Last 30 days (2751)
Last 365 days (32261)
2026 (24142)
2025 (31623)
2024 (36173)
2023 (41075)
2022 (52115)
2021 (56589)
2020 (54993)
2019 (47359)
2018 (35789)
2017 (34359)
2016 (34550)
2015 (39952)
2014 (33968)
2013 (28525)
2012 (30669)
2011 (30953)
2010 (29686)
Location
Africa (938)
Alabama (113)
Alaska (7)
Arizona (438)
Arkansas (14)
Asia (46400)
Australia (7490)
California (15712)
Canada (4276)
China (1838)
Colorado (666)
Connecticut (713)
Delaware (489)
Europe (106379)
Florida (2415)
Georgia (505)
Hawaii (5)
Idaho (68)
Illinois (1328)
India (134)
Indiana (717)
Iowa (30)
Japan (713)
Kansas (144)
Kentucky (64)
Louisiana (56)
Maine (93)
Maryland (1879)
Massachusetts (11291)
Michigan (421)
Minnesota (842)
Mississippi (7)
Missouri (173)
Montana (33)
Nebraska (31)
Nevada (175)
New Hampshire (87)
New Jersey (4149)
New Mexico (35)
New York (4101)
North Carolina (2022)
North Dakota (12)
Northern California (8012)
Ohio (490)
Oklahoma (28)
Oregon (49)
Pennsylvania (2964)
Puerto Rico (36)
Rhode Island (58)
South America (1337)
South Carolina (98)
South Dakota (2)
Southern California (6306)
Tennessee (259)
Texas (2578)
United States (55483)
Utah (452)
Vermont (2)
Virginia (382)
Washington D.C. (84)
Washington State (1241)
West Virginia (4)
Wisconsin (177)
Wyoming (5)
775,679 Results for "biopharma solutions baxter s pharma biotech partnering business".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Artificial intelligence
Deep Dive: How AI is now essential in biopharma
As Big Pharma adds AI technology to bolster drug development, a cadre of new, upstart biotechs are pushing drug discovery to new heights.
September 22, 2026
·
3 min read
·
Annalee Armstrong
Drug pricing
BIO 2026: Biopharma dealmakers seek to protect ‘premium pricing’ from Trump’s MFN policy
With drug pricing now embedded in U.S. policy, business development teams in biotech and pharma are changing the way they strike deals, including acknowledging policy uncertainties with renegotiation clauses.
June 23, 2026
·
2 min read
·
Annalee Armstrong
IPO
ADARx raises $446M in biotech’s third largest IPO of 2026, City files to go public
Two RNA biotechs, ADARx Pharmaceuticals and City Therapeutics, are taking advantage of the IPO frenzy, which has led to a total of 27 newly public biotechs so far this year.
September 25, 2026
·
2 min read
·
Gabrielle Masson
Editorial
Biotech’s China problem: An issue of national security or economic value for the US?
Congressional letters sent to the CEOs of Eli Lilly, Pfizer, Merck, BMS and AbbVie this week voicing concerns about the pharmas’ clinical trials in China highlight an ongoing discrepancy in how government and industry think about the rise of the Asian country’s biotech industry.
July 2, 2026
·
6 min read
·
Jef Akst
Venture capital
Frazier adds $1.1B+ to small and mid-sized biotech fund
Frazier’s life science fund has already benefited several successful biotechs, including Verona Pharma, which was acquired by Merck for $10 billion, and Carmot Therapeutics, which Roche bought for $2.7 billion.
September 11, 2026
·
2 min read
·
Tristan Manalac
Artificial intelligence
With tech backing, AI biotechs force biopharma into ‘fail-fast’ drug development
AI is quickly becoming a central force in drug development, from powering pharma engines to permanently rewiring the capital markets.
August 12, 2026
·
6 min read
·
Tristan Manalac
China
China’s surging biotech sector represents both competition and lifeline for the US
As Chinese companies push beyond “me-too” drugs and the country lays out a new five-year plan targeting a $522 billion–strong biotech industry by 2030, experts say more predictable funding and regulation could help the U.S. maintain its edge.
September 23, 2026
·
8 min read
·
Shawna Williams
Layoffs
August biopharma layoffs impact just over 500, down 90% year over year
Last month, biotech and pharma companies making or planning workforce cuts included three whose reductions will more than halve their workforces. Blueprint Medicines’ layoffs will affect the most employees.
September 10, 2026
·
6 min read
·
Angela Gabriel
Artificial intelligence
AI data becomes sticking point in biopharma dealmaking
As drug hunting gets more complex, where and how data is generated in partnerships between Big Pharmas and AI biotechs is becoming a headache for dealmakers.
July 22, 2026
·
2 min read
·
Annalee Armstrong
China
Beyond China: Five other overseas destinations for biopharma dollars
As geopolitical tensions between the U.S. and China grow increasingly complicated, here are five alternative territories for biotech investments.
September 9, 2026
·
8 min read
·
Tristan Manalac
1 of 77,568
Next
